Canada’s pharmacists worry that a lack of data about prescription management could see a repeat of the situation with diabetes and weight-loss drug Ozempic, in which thousands of doses have been mailed over the border to Americans.
Ozempic shipments to U.S. leave Canadian pharmacists fearing impact on drug supply
